KRYS Dividend: Krystal Biotech Inc Yield Insights

KRYS Financial

Krystal Biotech Inc

$217.46

1.11%

$2.4

At close: Dec 03, 16:00:00 GMT-5

$217.46

Pre-market: Dec 04, 06:30:04 GMT-5

Income

Balance sheet

Cash flow

Annual

Quarterly

KRYS Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	373	290	50	0	0	0
Revenue Growth (YoY)	55%	480%	--	--	--	--
Cost of Revenue	21	20	3	--	--	--
Gross Profit	351	270	47	--	--	--
Selling, General & Admin	136	113	98	77	40	15
Research & Development	56	53	46	42	27	17
Operating Expenses	193	167	144	120	68	33
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	186	95	12	-139	-69	-32
Income Tax Expense	-11	6	1	--	--	--
Net Income	198	89	10	-139	-69	-32
Net Income Growth	281%	790%	-107%	101%	115.99%	68%
Shares Outstanding (Diluted)	29.83	29.74	27.75	25.49	22.2	18.79
Shares Change (YoY)	0%	7%	9%	15%	18%	18%
EPS (Diluted)	6.66	2.99	0.39	-5.49	-3.13	-1.71
EPS Growth	277%	661%	-107%	75%	83%	43%
Free Cash Flow	165	119	-100	-153	-116	-40
Free Cash Flow Per Share	5.53	4	-3.6	-6	-5.22	-2.12
Gross Margin	94.1%	93.1%	94%	--	--	--
Operating Margin	42.35%	35.51%	-194%	0%	0%	0%
Profit Margin	53.08%	30.68%	20%	0%	0%	0%
Free Cash Flow Margin	44.23%	41.03%	-200%	0%	0%	0%
EBITDA	162	108	-92	-116	-66	-32
EBITDA Margin	43.43%	37.24%	-184%	0%	0%	0%
D&A For EBITDA	4	5	5	4	2	1
EBIT	158	103	-97	-120	-68	-33
EBIT Margin	42.35%	35.51%	-194%	0%	0%	0%
Effective Tax Rate	-5.91%	6.31%	8.33%	--	--	--